HIMABERB®
A high-purity berberine hydrochloride extract from wildcrafted Himalayan Berberis aristata roots, standardized to a minimum 97% berberine HCl by HPLC. Produced by aqueous extraction in an ISO-certified facility — an excipient-free, clean-label active for glucose, lipid, and metabolic health formulations.
A wildcrafted, high-purity berberine standardized for formulation reliability
Berberine is an isoquinoline alkaloid found across several plant genera, with one of the deepest clinical evidence bases of any botanical-derived metabolic ingredient — spanning glucose metabolism, lipid management, and gut microbiota research. Variability in source material and extraction method, however, means not all berberine on the market is created equal.
HIMABERB® is extracted from wildcrafted Berberis aristata roots sourced in the Himalayan region, using an aqueous extraction process with no excipients carried into the finished ingredient. The result is a yellow crystalline powder standardized to a minimum 97% berberine HCl by HPLC, with defined bulk density and particle size for consistent capsule, tablet, and powder-blend performance.
Ingredient Snapshot
- Botanical source: Wildcrafted Berberis aristata (Himalayan roots)
- Extraction: Aqueous process, excipient-free
- Standardization: Min. 97% berberine HCl by HPLC
- Production: ISO-certified facility
- Profile: Non-GMO, allergen-free, vegan, sustainably sourced
Multi-pathway metabolic activity
Berberine acts through several converging pathways rather than a single receptor target. It activates AMP-activated protein kinase (AMPK) in liver, skeletal muscle, and adipose tissue, improving cellular glucose uptake and lipid handling. In the liver, berberine upregulates LDL receptor (LDLR) expression via AMPK-ERK signaling and inhibition of miR-27a, improving LDL cholesterol clearance. Berberine also interacts with gut microbiota, promoting short-chain fatty acid (SCFA) production — including butyrate — that contributes to its systemic metabolic effects, a relevant consideration given berberine's inherently low oral bioavailability.
1. Berberis aristata Root
Wildcrafted, Himalayan-sourced2. Aqueous Extraction
Excipient-free, ISO-certified process3. ≥97% Berberine HCl
Standardized, HPLC-verified crystalline powder4. Multi-Pathway Activity
AMPK activation · LDLR upregulation · gut microbiota modulationMechanism references: Berberine in Cardiovascular & Metabolic Diseases, Theranostics · Gut Microbiome Mechanism, Frontiers, 2022
Meta-analytic evidence across glucose and lipid endpoints
Berberine has one of the larger clinical evidence bases of any metabolic-health botanical actives, with dozens of randomized controlled trials pooled into meta-analyses across glycemic and lipid outcomes.
Glycemic Control
Meta-analysis of 37 RCTs (n=3,048): berberine reduced fasting plasma glucose by 0.82 mmol/L, HbA1c by 0.63%, and 2-hour postprandial glucose by 1.16 mmol/L, all statistically significant vs. control.
Lipid Profile
Meta-analyses of randomized, placebo-controlled trials report LDL-C reductions of 0.38–0.46 mmol/L and triglyceride reductions of 0.34–0.37 mmol/L with berberine supplementation.
Gut-Liver Metabolic Axis
Mechanistic research links berberine's systemic effects to gut microbiota-derived short-chain fatty acids alongside direct AMPK activation in liver and muscle, offering a multi-pathway explanation for its metabolic activity.
Referenced meta-analyses reflect published research on berberine as a compound across multiple study populations and formulations, cited for scientific context; they do not represent proprietary clinical trials of HIMABERB® specifically. Berberine's oral bioavailability is inherently low, and trial designs vary in dose, duration, and formulation.
Where HIMABERB® fits in your product line
Glucose Metabolism
Supports healthy glucose metabolism, insulin sensitivity, and glucose tolerance.*
Cardiovascular Health
Supports healthy LDL cholesterol and triglyceride levels already within normal range.
Liver Health
Supports hepatic lipid handling and metabolic function.
Gut Microbiome
Interacts with gut microbiota to support short-chain fatty acid production.
*Represents outcomes from the referenced meta-analyses on berberine generally, not proprietary trials of HIMABERB®.
Ingredient specification summary
| Active ingredient | Berberine Hydrochloride |
| Botanical source | Wildcrafted Berberis aristata (roots) |
| Assay | Min. 97% berberine HCl by HPLC |
| Extraction method | Aqueous process, excipient-free |
| Recommended dosage | 500 mg – 1,500 mg per day |
| Appearance | Yellow crystalline powder, odorless, bitter, slightly water-soluble |
| Country of origin | India |
| Minimum order quantity | 25 kg |
| Categories | Cardiovascular Health · Glucose Metabolism · Gut Health · Hormonal Balance · Liver Health |
Clean label, consistently produced
Formulating a metabolic, glucose, or lipid-support product?
Get HIMABERB® specification sheets, certificates of analysis, and pricing direct from Pharma Base S.A.
This content describes ingredient technology and published research for formulator and manufacturer audiences. Statements have not been evaluated by the Food and Drug Administration or equivalent regulatory bodies. This ingredient is not intended to diagnose, treat, cure, or prevent any disease. Finished-product claims are the responsibility of the brand owner and are subject to applicable regulatory review in each market.